Form 4: CalciMedica Director Middleton Acquires Stock Options
SEC Form 4 Filing
Director Fred A. Middleton receives stock options in CalciMedica, Inc.
Summary
- Fred A. Middleton, a director and 10% owner of CalciMedica, Inc. acquired stock options on August 27, 2024.
- The options grant the right to buy 10,000 shares of common stock at an exercise price of $4.16.
- The options vest monthly over a one-year period starting March 28, 2024, and expire on August 26, 2034.
- Following the transaction, Middleton directly owns options for 10,000 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction. The granting of options is generally viewed as a positive incentive, but it's not a major event.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The granting of stock options to a director can align their interests with those of shareholders, potentially leading to increased shareholder value.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Start date for monthly vesting of the stock options. |
| August 27, 2024 | Date of the transaction where the stock options were acquired. |
| August 26, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.